[{"id":"fc69d563-200d-442d-b401-2949dd0628d0","acronym":"","url":"https://clinicaltrials.gov/study/NCT00471432","created_at":"2021-01-18T01:40:47.314Z","updated_at":"2024-07-02T16:35:41.034Z","phase":"Phase 1","brief_title":"OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors","source_id_and_acronym":"NCT00471432","lead_sponsor":"NCIC Clinical Trials Group","biomarkers":" CLU","pipe":"","alterations":" ","tags":["CLU"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e docetaxel • custirsen (OGX-011)"],"overall_status":"Completed","enrollment":" Enrollment 40","initiation":"Initiation: 04/04/2003","start_date":" 04/04/2003","primary_txt":" Primary completion: 03/09/2006","primary_completion_date":" 03/09/2006","study_txt":" Completion: 12/21/2009","study_completion_date":" 12/21/2009","last_update_posted":"2023-08-04"},{"id":"394ad8d3-e749-4ab7-a393-205351f42394","acronym":"","url":"https://clinicaltrials.gov/study/NCT00138918","created_at":"2021-01-18T00:28:30.121Z","updated_at":"2024-07-02T16:37:24.750Z","phase":"Phase 2","brief_title":"Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer","source_id_and_acronym":"NCT00138918","lead_sponsor":"University of British Columbia","biomarkers":" CLU","pipe":"","alterations":" ","tags":["CLU"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e custirsen (OGX-011)"],"overall_status":"Completed","enrollment":" Enrollment 20","initiation":"Initiation: 06/01/2005","start_date":" 06/01/2005","primary_txt":" Primary completion: 05/13/2008","primary_completion_date":" 05/13/2008","study_txt":" Completion: 05/13/2008","study_completion_date":" 05/13/2008","last_update_posted":"2017-03-03"}]